Genetic characterization on the nucleoprotein and fusion gene of wild-type measles virus circulating in Shanghai, 2001–2022

IF 3.5 4区医学 Q2 IMMUNOLOGY

Journal of Virus Eradication Pub Date : 2025-03-01 DOI:10.1016/j.jve.2025.100589

Yunyi Li , Xiaoxian Cui , Ai Lin , Wei Tang , Yuying Yang , Wanju Zhang , Jiayu Hu , Zhi Li , Yanqiu Zhou

{"title":"Genetic characterization on the nucleoprotein and fusion gene of wild-type measles virus circulating in Shanghai, 2001–2022","authors":"Yunyi Li , Xiaoxian Cui , Ai Lin , Wei Tang , Yuying Yang , Wanju Zhang , Jiayu Hu , Zhi Li , Yanqiu Zhou","doi":"10.1016/j.jve.2025.100589","DOIUrl":null,"url":null,"abstract":"<div><div>Measles is an acute and highly contagious viral disease that poses significant public health challenges globally. Since 2001, continuous virologic surveillance has been conducted in Shanghai, enabling a comprehensive analysis of the evolution of the nucleoprotein (N gene) and fusion gene (F gene) of the measles virus (MeV) over a 21-year period. Between 2001 and 2022, there were a total of 1405 MeV strains isolated by the Shanghai Center for Disease Control and prevention (SCDC), including 6 strains of genotype D8, 8 strains of genotype B3, 12 strains of genotype H1b, and the remaining strains of genotype H1a. Reverse transcription polymerase chain reaction (RT-PCR) was used to amplify the 3′ end of the N gene (450 nt) and the complete sequence of the F gene (1622 nt) from the viral isolates. Sequencing of the RT-PCR products was followed by nucleotide and amino acid phylogenetic analyses. The substitution rates were for the F and N genes in Shanghai were determined to be 0.89 × 10<sup>−3</sup> and 2.20 × 10<sup>−3</sup> substitutions site<sup>/</sup>year, respectively.</div><div>Globally, the nucleotide and amino acid similarities of the N gene among 13,498 MeV isolates ranged from 89.1 %–100.0 % and 90.2 %–100.0 %, respectively. Notably, the F gene exhibited 16 high-amino-acid-mutation sites, most of which differed among H1a MeV strains compared t<u>o</u> the Shanghai-191 vaccine strain. The deletion of the glycosylation site at aa 9–11(NVS) was primarily observed in H1a and H1b of MeV strains. However, critical functional sites in the F gene remained conserved.</div><div>In conclusion, the previously predominant indigenous H1a wild-type measles virus (MeV) has not been detected for over two years, with only imported MeV genotypes currently being identified. It is crucial to strengthen the surveillance of MeV genotypes to facilitate the timely identification and containment of imported measles cases, thereby preventing potential outbreaks.</div></div>","PeriodicalId":17552,"journal":{"name":"Journal of Virus Eradication","volume":"11 1","pages":"Article 100589"},"PeriodicalIF":3.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Virus Eradication","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2055664025000081","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Measles is an acute and highly contagious viral disease that poses significant public health challenges globally. Since 2001, continuous virologic surveillance has been conducted in Shanghai, enabling a comprehensive analysis of the evolution of the nucleoprotein (N gene) and fusion gene (F gene) of the measles virus (MeV) over a 21-year period. Between 2001 and 2022, there were a total of 1405 MeV strains isolated by the Shanghai Center for Disease Control and prevention (SCDC), including 6 strains of genotype D8, 8 strains of genotype B3, 12 strains of genotype H1b, and the remaining strains of genotype H1a. Reverse transcription polymerase chain reaction (RT-PCR) was used to amplify the 3′ end of the N gene (450 nt) and the complete sequence of the F gene (1622 nt) from the viral isolates. Sequencing of the RT-PCR products was followed by nucleotide and amino acid phylogenetic analyses. The substitution rates were for the F and N genes in Shanghai were determined to be 0.89 × 10⁻³ and 2.20 × 10⁻³ substitutions site^/year, respectively.

Globally, the nucleotide and amino acid similarities of the N gene among 13,498 MeV isolates ranged from 89.1 %–100.0 % and 90.2 %–100.0 %, respectively. Notably, the F gene exhibited 16 high-amino-acid-mutation sites, most of which differed among H1a MeV strains compared to the Shanghai-191 vaccine strain. The deletion of the glycosylation site at aa 9–11(NVS) was primarily observed in H1a and H1b of MeV strains. However, critical functional sites in the F gene remained conserved.

In conclusion, the previously predominant indigenous H1a wild-type measles virus (MeV) has not been detected for over two years, with only imported MeV genotypes currently being identified. It is crucial to strengthen the surveillance of MeV genotypes to facilitate the timely identification and containment of imported measles cases, thereby preventing potential outbreaks.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Virus Eradication Medicine-Public Health, Environmental and Occupational Health

CiteScore

6.10

自引率

1.80%

发文量

审稿时长

39 weeks

期刊介绍： The Journal of Virus Eradication aims to provide a specialist, open-access forum to publish work in the rapidly developing field of virus eradication. The Journal covers all human viruses, in the context of new therapeutic strategies, as well as societal eradication of viral infections with preventive interventions. The Journal is aimed at the international community involved in the prevention and management of viral infections. It provides an academic forum for the publication of original research into viral reservoirs, viral persistence and virus eradication and ultimately development of cures. The Journal not only publishes original research, but provides an opportunity for opinions, reviews, case studies and comments on the published literature. It focusses on evidence-based medicine as the major thrust in the successful management of viral infections.The Journal encompasses virological, immunological, epidemiological, modelling, pharmacological, pre-clinical and in vitro, as well as clinical, data including but not limited to drugs, immunotherapy and gene therapy. It is an important source of information on the development of vaccine programs and preventative measures aimed at virus eradication.